Selegiline reduces adiposity induced by high‐fat, high‐sucrose diet in male rats
British Journal of Pharmacology2018Vol. 175(18), pp. 3713–3726
Citations Over TimeTop 21% of 2018 papers
Csilla Terézia Nagy, Gábor Koncsos, Zoltán V. Varga, Tamás Baranyai, Sebestyén Tuza, Ferenc Kassai, Alíz Judit Ernyey, István Gyertyán, Kornél Király, Attila Oláh, Tamás Radovits, Béla Merkely, Nóra Bukosza, Gábor Szénási, Péter Hamar, Domokos Máthé, Krisztián Szigeti, Csilla Pelyhe, Marek Jelemenský, Zsófia Onódi, Zsuzsanna Helyes, Rainer Schulz, Zoltán Giricz, Péter Ferdinandy
Abstract
Selegiline reduced adiposity, changes in adipose tissue energy metabolism and adipose inflammation induced by HFS diet without affecting the increased body weight, impairment of glucose homeostasis, or behaviour. These results suggest that selegiline could mitigate harmful effects of visceral adiposity.
Related Papers
- → Selegiline for Treating Parkinson’s Disease(2022)3 cited
- → Early Addition of Selegiline to L-Dopa Treatment is Beneficial for Patients With Parkinson Disease(2010)14 cited
- ["Widening horizons" in the clinical application of selegiline].(1992)
- → Long-Term Safety and Efficacy of Selegiline in the Treatment of Parkinson’s Disease(1997)